Caribbean Update - MERCK’S US$325 MILLION EXPANSION.(Brief Article)
Drugmaker Merck & Co. said it will invest more than US$325 million in new facilities at its five Barceloneta plants, where it produces the osteoporosis treatment Fosamax, hypertension drug Vasotec and other best-selling prescription drugs, reports The San Juan Star (April 27, 2001):
Related Results
FDA unleashes 16 generics of VasotecMerck gets good news on VasotecWatson’s generic Vasotec gets OKENALAPRIL.(Vasotec from Merck)(Company Business and Marketing)(Brief Article)Biovail Corp. (Active Pharmaceutical Ingredient Watch).(purchase of Vasotec,…
In contrast to other plant closings, at least four pharmaceutical firms are pumping money into their Puerto Rico operations. Eli Lilly a week earlier said it would invest US$250 …
Read the rest of this article with a Free Trial at HighBeam Research.
